Add-on Acquisition • Life Science

BioAgilytix Acquires 360biolabs

On August 16, 2021, BioAgilytix acquired life science company 360biolabs

Acquisition Context

This is BioAgilytix’s 3rd transaction in the Life Science sector.
This is BioAgilytix’s 1st transaction in Australia.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	August 16, 2021
Target	360biolabs
Sector	Life Science
Buyer(s)	BioAgilytix
Deal Type	Add-on Acquisition

Target Company

360biolabs

Melbourne, Australia

360biolabs is a comprehensive specialty laboratory that provides pharmacokinetic (PK) and pharmacodynamic (PD) assay services that support small molecule, biologic, vaccine, and other innovative therapeutic solutions to human health. The company's industry experienced technical team, known for their ability to successfully deliver technically challenging assays, 360biolabs supports global Pharmaceutical and biotech companies in a diverse and growing range of therapeutic areas. It delivers global regulatory compliant assays and reports following ISO/IEC 17025, ISO 15189, OECD GLP, GCLP, and ICH GCP with a focus on quality. 360biolabs was formed in 2008 and is based in Melbourne, Australia.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

BioAgilytix

Durham, North Carolina, United States

Category	Company
Founded	2008
Sector	Life Science

DESCRIPTION

BioAgilytix is a bioanalytical testing laboratory focused on large molecule bioanalysis for the pharmaceutical, biotechnology and agriculture industries. BioAgilytix Lab's mission is to provide outsourced analysis of biological samples that support the work of companies seeking regulatory approval of their biopharmaceutical and agricultural products. BioAgilytix was founded in 2008 and is based in Durham, North Carolina.

Deal Context for Buyer	#
Overall	3 of 3
Sector: Life Science	3 of 3
Type: Add-on Acquisition	3 of 3
Country: Australia	1 of 1
Year: 2021	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2019-11-04	Cambridge Biomedical Boston, Massachusetts, United States Cambridge Biomedical, Inc. is a contract research organization specializes in large molecule bioanalysis. Cambridge Biomedical was founded in 1997 and is based in Boston, Massachusetts.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2019-11-04

Cambridge Biomedical

Boston, Massachusetts, United States

Cambridge Biomedical, Inc. is a contract research organization specializes in large molecule bioanalysis. Cambridge Biomedical was founded in 1997 and is based in Boston, Massachusetts.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Australia M&A - 2021 M&A